Evidence map›Paper›PMID 26939622›Full record

ArticleGut microbes2016

Step-up fecal microbiota transplantation (FMT) strategy.

Bota Cui, Pan Li, Lijuan Xu, Zhaoyuan Peng, Jie Xiang, Zhi He, Ting Zhang, Guozhong Ji, Yongzhan Nie, Kaichun Wu and 2 more

Registry-linked trialAbstract readEvaluation Study
In one paragraph

Article in Gut microbes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02889627 (Efficacy and Safety of Fecal Microbiota Transplantation for Epilepsy), which is not on this map. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02889627 phase2 / phase3unknown statusnot on this map

Efficacy and Safety of Fecal Microbiota Transplantation for Epilepsy

TypeinterventionalSponsorThe Second Hospital of Nanjing Medical UniversityRan2016 to 2025Enrolled50ConditionsEpilepsyArmsFecal microbiota suspension
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Fecal Microbiota Transplantation: A Prospective Treatment for Type 2 Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  19. The Evolving Landscape of Fecal Microbial Transplantation.Clinical reviews in allergy & immunology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bota Cuia Medical Center for Digestive Diseases , the Second Affiliated Hospital of Nanjing Medical University , Nanjing , China.
Pan Lia Medical Center for Digestive Diseases , the Second Affiliated Hospital of Nanjing Medical University , Nanjing , China.
Lijuan Xua Medical Center for Digestive Diseases , the Second Affiliated Hospital of Nanjing Medical University , Nanjing , China.
Zhaoyuan Penga Medical Center for Digestive Diseases , the Second Affiliated Hospital of Nanjing Medical University , Nanjing , China.
Jie Xianga Medical Center for Digestive Diseases , the Second Affiliated Hospital of Nanjing Medical University , Nanjing , China.
Zhi Hea Medical Center for Digestive Diseases , the Second Affiliated Hospital of Nanjing Medical University , Nanjing , China.
Ting Zhanga Medical Center for Digestive Diseases , the Second Affiliated Hospital of Nanjing Medical University , Nanjing , China.
Guozhong Jia Medical Center for Digestive Diseases , the Second Affiliated Hospital of Nanjing Medical University , Nanjing , China.
Yongzhan Niec State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases , the Fourth Military Medical University , Xi'an , China.
Kaichun Wuc State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases , the Fourth Military Medical University , Xi'an , China.
Daiming Fanc State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases , the Fourth Military Medical University , Xi'an , China.
Faming Zhanga Medical Center for Digestive Diseases , the Second Affiliated Hospital of Nanjing Medical University , Nanjing , China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut dysbiosis is a characteristic of inflammatory bowel disease (IBD) and is believed to play a role in the pathogenesis of IBD. Fecal microbiota transplantation (FMT) is an effective strategy to restore intestinal microbial diversity and has been reported to have a potential therapeutic value in IBD. Our recent study reported a holistic integrative therapy called "step-up FMT strategy," which was beneficial in treating steroid-dependent IBD patients. This strategy consists of scheduled FMTs combined with steroids, anti-TNF-α antibody treatment or enteral nutrition. Herein, we will elaborate the strategy thoroughly, introducing the concept, potential indication, methodology, and safety of "step-up FMT strategy" in detail.

Indexed as

Gastrointestinal MicrobiomeBacteriaFecal Microbiota TransplantationFecesGastrointestinal TractHumansInflammatory Bowel DiseasesdysbiosisInflammatory bowel diseaseStep-up fecal microbiota transplantationSteroidsUlcerative colitis

Identifiers

PMID26939622
PMCPMC4988439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.